SAN JOSE, Calif., Sept. 16, 2016 /PRNewswire/ -- Language solutions from Moravia's Life Sciences Practice will be on full display at booth #326 during the RAPS Regulatory Conference 2016 in San Jose, Calif., Sept. 17-20.
The life sciences sector is one of the most internationalized industries in the world today—and it's also one of the most regulated. Moravia, which is ISO 9001, ISO 13485 and ISO 17100-certified, helps medical device, pharmaceutical and other healthcare companies meet global regulatory requirements by providing language solutions that support their efforts—from clinical trials to product launch.
"For many companies in the life sciences sector, more than 50 percent of their business comes from international markets," said Libor Safar, Director of Marketing at Moravia. "Regulations that drive translation requirements are undergoing major changes globally. Whether it's the new EU medical device regulations, the global implementation of UDI, or new postmarketing requirements, companies need to comply and make specific content available in local languages. That's where we come in."
With offices around the world, Moravia has accumulated industry-specific knowledge and capabilities in the life sciences space, including trained and qualified resources, in-country healthcare subject matter experts, and life-sciences-specific processes, procedures and infrastructure. This ensures that Moravia can provide world-class services—including translation services for medical devices, pharmaceutical products and clinical trials—for any healthcare company in any market around the world.
About Moravia
Moravia is a leading globalization solution provider, enabling companies in the information technology, e-learning, travel and life sciences industries to enter global markets with high-quality multilingual products. (www.moravia.com)
Logo - http://photos.prnewswire.com/prnh/20150122/170814LOGO
SOURCE Moravia
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article